TY - JOUR AU - Foulkes, W. D. AU - Smith, I. E. AU - Reis-Filho, J. S. PY - 2010 DA - 2010// TI - Triple-negative breast cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMra1001389 DO - 10.1056/NEJMra1001389 ID - Foulkes2010 ER - TY - JOUR AU - Stevens, K. N. AU - Vachon, C. M. AU - Couch, F. J. PY - 2013 DA - 2013// TI - Genetic susceptibility to triple-negative breast cancer JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-1699 DO - 10.1158/0008-5472.CAN-12-1699 ID - Stevens2013 ER - TY - JOUR AU - Metcalfe, K. AU - Lubinski, J. AU - Lynch, H. T. AU - Ghadirian, P. AU - Foulkes, W. D. AU - Kim-Sing, C. AU - Neuhausen, S. AU - Tung, N. AU - Rosen, B. AU - Gronwald, J. PY - 2010 DA - 2010// TI - Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq443 DO - 10.1093/jnci/djq443 ID - Metcalfe2010 ER - TY - JOUR AU - Network, C. G. A. PY - 2012 DA - 2012// TI - Comprehensive molecular portraits of human breast tumours JO - Nature VL - 490 UR - https://doi.org/10.1038/nature11412 DO - 10.1038/nature11412 ID - Network2012 ER - TY - STD TI - National Collaborating Centre for Cancer (UK): Familial Breast Cancer: Classification and Care of People at Risk of Familial Breast Cancer and Management of Breast Cancer and Related Risks in People with a Family History of Breast Cancer. Cardiff (UK): National Collaborating Centre for Cancer (UK); 2013 . ID - ref5 ER - TY - JOUR AU - Kast, K. AU - Rhiem, K. AU - Wappenschmidt, B. AU - Hahnen, E. AU - Hauke, J. AU - Bluemcke, B. AU - Zarghooni, V. AU - Herold, N. AU - Ditsch, N. AU - Kiechle, M. PY - 2016 DA - 2016// TI - Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer JO - J Med Genet VL - 53 UR - https://doi.org/10.1136/jmedgenet-2015-103672 DO - 10.1136/jmedgenet-2015-103672 ID - Kast2016 ER - TY - JOUR AU - von Minckwitz, G. AU - Schneeweiss, A. AU - Loibl, S. AU - Salat, C. AU - Denkert, C. AU - Rezai, M. AU - Blohmer, J. U. AU - Jackisch, C. AU - Paepke, S. AU - Gerber, B. PY - 2014 DA - 2014// TI - Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70160-3 DO - 10.1016/S1470-2045(14)70160-3 ID - von Minckwitz2014 ER - TY - STD TI - Hahnen E, Lederer B, Hauke J, Loibl S, Krober S, Schneeweiss A, Denkert C, Fasching PA, Blohmer JU, Jackisch C, et al. Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the GeparSixto randomized clinical trial. JAMA Oncol. 2017;3(10):1378–85. ID - ref8 ER - TY - JOUR AU - Arnold, N. AU - Gross, E. AU - Schwarz-Boeger, U. AU - Pfisterer, J. AU - Jonat, W. AU - Kiechle, M. PY - 1999 DA - 1999// TI - A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers JO - Hum Mutat VL - 14 UR - https://doi.org/3.0.CO;2-C DO - 3.0.CO;2-C ID - Arnold1999 ER - TY - JOUR AU - Gross, E. AU - Arnold, N. AU - Goette, J. AU - Schwarz-Boeger, U. AU - Kiechle, M. PY - 1999 DA - 1999// TI - A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC JO - Hum Genet VL - 105 UR - https://doi.org/10.1007/s004399900092 DO - 10.1007/s004399900092 ID - Gross1999 ER - TY - JOUR AU - Plon, S. E. AU - Eccles, D. M. AU - Easton, D. AU - Foulkes, W. D. AU - Genuardi, M. AU - Greenblatt, M. S. AU - Hogervorst, F. B. AU - Hoogerbrugge, N. AU - Spurdle, A. B. AU - Tavtigian, S. V. PY - 2008 DA - 2008// TI - Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results JO - Hum Mutat VL - 29 UR - https://doi.org/10.1002/humu.20880 DO - 10.1002/humu.20880 ID - Plon2008 ER - TY - JOUR AU - Spurdle, A. B. AU - Healey, S. AU - Devereau, A. AU - Hogervorst, F. B. AU - Monteiro, A. N. AU - Nathanson, K. L. AU - Radice, P. AU - Stoppa-Lyonnet, D. AU - Tavtigian, S. AU - Wappenschmidt, B. PY - 2012 DA - 2012// TI - ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes JO - Hum Mutat VL - 33 UR - https://doi.org/10.1002/humu.21628 DO - 10.1002/humu.21628 ID - Spurdle2012 ER - TY - JOUR AU - Couch, F. J. AU - Hart, S. N. AU - Sharma, P. AU - Toland, A. E. AU - Wang, X. AU - Miron, P. AU - Olson, J. E. AU - Godwin, A. K. AU - Pankratz, V. S. AU - Olswold, C. PY - 2015 DA - 2015// TI - Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.1414 DO - 10.1200/JCO.2014.57.1414 ID - Couch2015 ER - TY - JOUR AU - Buys, S. S. AU - Sandbach, J. F. AU - Gammon, A. AU - Patel, G. AU - Kidd, J. AU - Brown, K. L. AU - Sharma, L. AU - Saam, J. AU - Lancaster, J. AU - Daly, M. B. PY - 2017 DA - 2017// TI - A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes JO - Cancer VL - 123 UR - https://doi.org/10.1002/cncr.30498 DO - 10.1002/cncr.30498 ID - Buys2017 ER - TY - JOUR AU - Zhang, J. AU - Pei, R. AU - Pang, Z. AU - Ouyang, T. AU - Li, J. AU - Wang, T. AU - Fan, Z. AU - Fan, T. AU - Lin, B. AU - Xie, Y. PY - 2012 DA - 2012// TI - Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1596-x DO - 10.1007/s10549-011-1596-x ID - Zhang2012 ER - TY - JOUR AU - Gonzalez-Rivera, M. AU - Lobo, M. AU - Lopez-Tarruella, S. AU - Jerez, Y. AU - Del Monte-Millan, M. AU - Massarrah, T. AU - Ramos-Medina, R. AU - Ocana, I. AU - Picornell, A. AU - Garzon, S. S. PY - 2016 DA - 2016// TI - Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial JO - Breast Cancer Res Treat VL - 156 UR - https://doi.org/10.1007/s10549-016-3792-1 DO - 10.1007/s10549-016-3792-1 ID - Gonzalez-Rivera2016 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Timms, K. M. AU - Liu, S. AU - Chen, H. AU - Litton, J. K. AU - Potter, J. AU - Lanchbury, J. S. AU - Stemke-Hale, K. AU - Hennessy, B. T. AU - Arun, B. K. PY - 2011 DA - 2011// TI - Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2560 DO - 10.1158/1078-0432.CCR-10-2560 ID - Gonzalez-Angulo2011 ER - TY - JOUR AU - Wong-Brown, M. W. AU - Meldrum, C. J. AU - Carpenter, J. E. AU - Clarke, C. L. AU - Narod, S. A. AU - Jakubowska, A. AU - Rudnicka, H. AU - Lubinski, J. AU - Scott, R. J. PY - 2015 DA - 2015// TI - Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer JO - Breast Cancer Res Treat VL - 150 UR - https://doi.org/10.1007/s10549-015-3293-7 DO - 10.1007/s10549-015-3293-7 ID - Wong-Brown2015 ER - TY - JOUR AU - Sharma, P. AU - Klemp, J. R. AU - Kimler, B. F. AU - Mahnken, J. D. AU - Geier, L. J. AU - Khan, Q. J. AU - Elia, M. AU - Connor, C. S. AU - McGinness, M. K. AU - Mammen, J. M. PY - 2014 DA - 2014// TI - Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing JO - Breast Cancer Res Treat VL - 145 UR - https://doi.org/10.1007/s10549-014-2980-0 DO - 10.1007/s10549-014-2980-0 ID - Sharma2014 ER - TY - JOUR AU - Rummel, S. AU - Varner, E. AU - Shriver, C. D. AU - Ellsworth, R. E. PY - 2013 DA - 2013// TI - Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer JO - Breast Cancer Res Treat VL - 137 UR - https://doi.org/10.1007/s10549-012-2348-2 DO - 10.1007/s10549-012-2348-2 ID - Rummel2013 ER - TY - JOUR AU - Fostira, F. AU - Tsitlaidou, M. AU - Papadimitriou, C. AU - Pertesi, M. AU - Timotheadou, E. AU - Stavropoulou, A. V. AU - Glentis, S. AU - Bournakis, E. AU - Bobos, M. AU - Pectasides, D. PY - 2012 DA - 2012// TI - Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic cooperative oncology group study JO - Breast Cancer Res Treat VL - 134 UR - https://doi.org/10.1007/s10549-012-2021-9 DO - 10.1007/s10549-012-2021-9 ID - Fostira2012 ER - TY - JOUR AU - Hartman, A. R. AU - Kaldate, R. R. AU - Sailer, L. M. AU - Painter, L. AU - Grier, C. E. AU - Endsley, R. R. AU - Griffin, M. AU - Hamilton, S. A. AU - Frye, C. A. AU - Silberman, M. A. PY - 2012 DA - 2012// TI - Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26576 DO - 10.1002/cncr.26576 ID - Hartman2012 ER - TY - JOUR AU - D'Andrea, E. AU - Marzuillo, C. AU - De Vito, C. AU - Di Marco, M. AU - Pitini, E. AU - Vacchio, M. R. AU - Villari, P. PY - 2016 DA - 2016// TI - Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations JO - Genet Med VL - 18 UR - https://doi.org/10.1038/gim.2016.29 DO - 10.1038/gim.2016.29 ID - D'Andrea2016 ER -